3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Esophageal Neoplasms
5
Adenocarcinoma Of Esophagus
5
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Rectal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Multiple Myeloma
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Renal Cell
2
Breast Carcinoma In Situ
2
Vomiting
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Rhabdomyosarcoma
1
Prostate Adenocarcinoma
1
Ovarian Neoplasms
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Vincristine
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Dactinomycin
4
Radiotherapy
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Radiotherapy, Conformal
2
Radiation
2
LY3023414
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
thymoglobulin
1
sargramostim
1
pembrolizumab
1
lorvotuzumab mertansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Wilms Tumor
×
Neoadjuvant Therapy
×
Clear all
No trials found.